Mortality and complications following stabilization of femoral metastatic lesions: a population-based study of regional variation and outcome

• Published in: Canadian Journal of Surgery Vol. 52; no. 4; pp. 302 - 308
• Main Authors: Ristevski, Bill, MD, MSc, Jenkinson, Richard J., MD, Stephen, David J.G., MD, Finkelstein, Joel, MD, Schemitsch, Emil H., MD, McKee, Michael D., MD, Kreder, Hans J., MD, MPH
• Format: Journal Article
• Language: English
• Published: Canada CMA Impact Inc 01.08.2009; CMA Impact, Inc; Canadian Medical Association
• Subjects: Comorbidity; Complications and side effects; Fractures; Metastasis; Mortality; Orthopedic surgery; Patient outcomes; Patients; Statistics; Studies; Surgery; Canada; Ontario Canada
• ISSN: 0008-428X; 1488-2310
• DOI: 10.1016/S0008-428X(09)50098-7

Background It is considered that patients at risk for spontaneous fracture due to metastatic lesions should undergo surgical stabilization before fracture occurs; however, prophylactic stabilization is associated with surgical morbidity and mortality. We sought to compare pathological fracture fixation versus prophylactic stabilization of diaphyseal femoral lesions for patients with femoral metastases and assess the rate of prophylactic surgery completed in all regions of Ontario. Methods Using population data sets, we identified all patients who had undergone femoral stabilization, either for pathological femoral fractures or for prophylactic fixation of femoral metastases before pathological fractures, between 1992 and 1997 in Ontario. We compared the rates of survival, serious medical and surgical complications and length of stay in hospital between the 2 groups. Results A total of 624 patients underwent surgical stabilization for femoral metastases. The most common sites of primary metastases were the lungs (26%), breasts (16%), kidneys (6%) and prostate (6%); 46% of patients had other or multiple primary metastases. Overall, 37% of lesions were fixed prophylactically, with wide variation by region (17.6%–72.2%). Patients who underwent prophylactic stabilization had better overall survival at all postoperative time points. This held true after adjusting for age, sex, comorbidities and type of cancer ( p < 0.001). Conclusion These data demonstrate a survival advantage with prophylactic fixation of metastatic femoral lesions combined with a relatively low perioperative risk excluding concomitant bilateral procedures. Ontario regional rates of prophylactic fixation vary enormously, with most patients not receiving prophylactic treatment.